Insider Shareholders with Direct Ownership of Entrada Therapeutics, Inc. (TRDA)
This section provides a comprehensive overview of the insiders with direct ownership of Entrada Therapeutics, Inc. (TRDA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Entrada Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dipal Doshi
CEO |
425,225 | 125,648 | 424,387 $4.49 Million | 55 |
Mar 03, 2025
Reduced 3.97%
|
|
Natarajan Sethuraman
President, Research & Develop. |
164,882 | 95,785 | 199,659 $2.11 Million | 33 |
Mar 03, 2025
Reduced 2.98%
|
|
Nathan J Dowden
President & COO |
233,395 | 99,734 | 180,805 $1.91 Million | 37 |
Mar 03, 2025
Reduced 2.77%
|
|
Kory James Wentworth
Chief Financial Officer |
217,448 | 101,463 | 111,320 $1.18 Million | 61 |
Mar 03, 2025
Reduced 4.24%
|
|
Peter S Kim
Director |
57,286 | 0 | 104,330 $1.1 Million | 12 |
Jun 03, 2024
Added 10.25%
|
|
Nerissa Kreher
Chief Medical Officer |
118,026 | 63,789 | 40,037 $423,591 | 35 |
Sep 06, 2023
Reduced 0.05%
|
|
John F Crowley
Director |
5,000 | 0 | 5,000 $52,900 | 1 |
Jan 12, 2022
Added 50.0%
|